Folgen
Jianda Yuan MD. Ph.D.
Jianda Yuan MD. Ph.D.
Bestätigte E-Mail-Adresse bei mskcc.org
Titel
Zitiert von
Zitiert von
Jahr
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
NA Rizvi, MD Hellmann, A Snyder, P Kvistborg, V Makarov, JJ Havel, ...
Science 348 (6230), 124-128, 2015
79752015
Genetic basis for clinical response to CTLA-4 blockade in melanoma
A Snyder, V Makarov, T Merghoub, J Yuan, JM Zaretsky, A Desrichard, ...
New England Journal of Medicine 371 (23), 2189-2199, 2014
44312014
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
H Peinado, M Alečković, S Lavotshkin, I Matei, B Costa-Silva, ...
Nature medicine 18 (6), 883-891, 2012
38252012
Immunologic correlates of the abscopal effect in a patient with melanoma
MA Postow, MK Callahan, CA Barker, Y Yamada, J Yuan, S Kitano, Z Mu, ...
New England Journal of Medicine 366 (10), 925-931, 2012
21382012
Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4
CC Chang, R Ciubotariu, JS Manavalan, J Yuan, AI Colovai, F Piazza, ...
Nature immunology 3 (3), 237-243, 2002
10642002
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
VP Balachandran, MJ Cavnar, S Zeng, ZM Bamboat, LM Ocuin, H Obaid, ...
Nature medicine 17 (9), 1094-1100, 2011
5912011
Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab
A Martens, K Wistuba-Hamprecht, MG Foppen, J Yuan, MA Postow, ...
Clinical Cancer Research 22 (12), 2908-2918, 2016
5562016
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial
BC Carthon, JD Wolchok, J Yuan, A Kamat, DS Ng Tang, J Sun, G Ku, ...
Clinical Cancer Research 16 (10), 2861-2871, 2010
5292010
Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival
GY Ku, J Yuan, DB Page, SEA Schroeder, KS Panageas, RD Carvajal, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2010
4902010
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
J Yuan, S Gnjatic, H Li, S Powel, HF Gallardo, E Ritter, GY Ku, ...
Proceedings of the National Academy of Sciences 105 (51), 20410-20415, 2008
4052008
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
J Yuan, M Adamow, BA Ginsberg, TS Rasalan, E Ritter, HF Gallardo, Y Xu, ...
Proceedings of the National Academy of Sciences 108 (40), 16723-16728, 2011
3952011
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
W Ma, BM Gilligan, J Yuan, T Li
Journal of hematology & oncology 9, 1-21, 2016
3652016
Indoleamine 2, 3-dioxygenase–expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells
DJ Chung, M Rossi, E Romano, J Ghith, J Yuan, DH Munn, JW Young
Blood, The Journal of the American Society of Hematology 114 (3), 555-563, 2009
3062009
Novel technologies and emerging biomarkers for personalized cancer immunotherapy
J Yuan, PS Hegde, R Clynes, PG Foukas, A Harari, TO Kleen, P Kvistborg, ...
Journal for immunotherapy of cancer 4, 1-25, 2016
2582016
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
S Janetzki, KS Panageas, L Ben-Porat, J Boyer, CM Britten, TM Clay, ...
Cancer Immunology, Immunotherapy 57, 303-315, 2008
2222008
Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either …
G Ratzinger, J Baggers, MA de Cos, J Yuan, T Dao, JL Reagan, C Munz, ...
The Journal of Immunology 173 (4), 2780-2791, 2004
2142004
Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either …
G Ratzinger, J Baggers, MA de Cos, J Yuan, T Dao, JL Reagan, C Munz, ...
The Journal of Immunology 173 (4), 2780-2791, 2004
2142004
Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy
D Ng Tang, Y Shen, J Sun, S Wen, JD Wolchok, J Yuan, JP Allison, ...
Cancer immunology research 1 (4), 229-234, 2013
2112013
Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
MA Postow, M Manuel, P Wong, J Yuan, Z Dong, C Liu, S Perez, ...
Journal for immunotherapy of cancer 3, 1-5, 2015
2072015
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation
MA Perales, JD Goldberg, J Yuan, G Koehne, L Lechner, ...
Blood, The Journal of the American Society of Hematology 120 (24), 4882-4891, 2012
1962012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20